In a significant leap forward for cardiovascular care, Brightflow SAS has successfully raised €16.5 million in Series A funding. This impressive round of equity investment is set to propel the company’s groundbreaking efforts in developing a minimally invasive solution for end-stage heart failure. Based in France, Brightflow SAS is at the forefront of innovation in…
In a significant leap forward for orthopedic advancements, ABANZA, a frontrunner in innovative soft tissue repair solutions, proudly announces the successful closure of its Pre-Series A funding round, amassing $5 million. This pivotal financial injection was spearheaded by a Family Office with a robust portfolio in medical device investments, complemented by contributions from private investors…
In a significant boost to the fight against lung cancer, HEPTA Medical, a pioneering medical device company specializing in minimally invasive thermal ablation therapy, has successfully completed a €5.7 million Series A funding round. The investment was led by BPI France and supported by M&L Healthcare and Clery IG. Founded in 2019 by Sofinnova Partners…
In a significant boost to the field of healthcare innovation, Segmed, Inc. has announced the successful completion of its $10.4 million Series A funding round. This latest round, which saw an oversubscription, was spearheaded by iGan Partners and Advocate Health, with notable contributions from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer…
Myolex, Inc., a pioneering company in muscle health assessment technology, has been awarded a grant of up to $2.2 million from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH). This Direct-to-Phase 2 Small Business Innovation Research (SBIR) grant will advance Myolex’s electrical impedance myography (EIM)…
AmorSui, an innovative leader in sustainable personal protective equipment (PPE), has announced the completion of a $3.5 million seed funding round. This strategic investment, led by Gold House Ventures, The MBA Fund, and The Rev Up Fund, will fuel the company’s mission to enhance the safety and environmental responsibility of medical supplies. AmorSui aims to…
Prana Thoracic, a medical device company pioneering minimally invasive lung tissue excision, today announced the closing of a $3 million extension to its Series A financing round. The additional funding brings the total capital raised to $9 million. The oversubscribed round reflects strong investor confidence in the company’s innovative approach to addressing early-stage lung cancer. …
Loci Orthopaedics Ltd, a pioneering orthopaedic medical device company, has successfully concluded a Series A financing round with €12.8 million, oversubscribed and led by prominent investors Seroba, Johnson & Johnson Innovation, JJDC, Inc., and the European Innovation Council (EIC) Fund. This funding marks a significant milestone for Loci Orthopaedics as it accelerates the development and…
Novocuff, Inc., a trailblazing medical device company specializing in improving pregnancy outcomes and combating preterm births, has successfully concluded an oversubscribed $26 million Series A funding round. The financing, initially kicked off with a $2 million seed round, was led by AXA IM Alts through its Global Healthcare Private Equity Strategy, with substantial contributions from…
